文献速递生殖医学

Fertistartkit在法国辅助生殖临床实践中的真实世界有效性:一项回顾性多中心研究

Real-world effectiveness of Fertistartkit® treatment in women undergoing ART in French clinical practice: a retrospective multicentre study.
PubMed 文献 · Reprod Biomed Online · 2020-01-09

该回顾性多中心队列研究纳入2016年4月至2017年11月法国12个辅助生殖中心使用Fertistartkit进行卵巢刺激的914名女性共1006个周期,随访至2018年2月。主要结局为获卵数,平均每周期获卵9.5±6.8个,持续妊娠率每启动周期26.0%(95%CI 24.1-27.9),每穿刺周期27.0%(95%CI 25.0-29.0)。结论提示Fertistartkit是卵巢刺激的有效选择。

要点

  • 平均每周期获卵9.5±6.8个,成熟卵母细胞7.4±5.5个。
  • 每启动周期持续妊娠率26.0%(95%CI 24.1-27.9)。
  • 每穿刺周期持续妊娠率27.0%(95%CI 25.0-29.0)。

核心结论

  • 真实世界数据显示Fertistartkit是卵巢刺激的有效选择。

研究设计与样本

  • 回顾性队列研究,纳入法国12个辅助生殖中心914名女性共1006个周期,数据收集自2016年4月至2017年11月,随访至2018年2月。

主要发现

  • 首次卵巢刺激时女性年龄34.9±5.0岁,体重指数中位数22.7 kg/m²。
  • Fertistartkit起始剂量中位数300 IU(IQR 150-300 IU),刺激10天(IQR 9-11天),总剂量中位数2700 IU(IQR 1800-3300 IU)。
  • 平均每周期获卵9.5±6.8个,平均每周期成熟卵母细胞7.4±5.5个。
  • 每启动周期持续妊娠率26.0%(95%CI 24.1-27.9),每穿刺周期持续妊娠率27.0%(95%CI 25.0-29.0)。

临床怎么用

  • 在真实临床实践中,Fertistartkit可用于辅助生殖技术中的卵巢刺激,获卵数和持续妊娠率数据可供临床参考。

局限性

  • 本研究为回顾性队列研究,仅描述真实世界管理情况,未设对照组。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: What is the real-world effectiveness of Fertistartkit® in women undergoing assisted reproductive technology (ART)? DESIGN: Retrospective cohort study including anonymized data of women undergoing ovarian stimulation for ART with Fertistartkit between April 2016 and November 2017 and follow-up of clinical outcomes up to February 2018. Data were collected from the electronic patient databases of 12 French ART centres. The main outcome was number of oocytes retrieved. All data were categorized according to female age (<25, 25-29, 30-34, 35-37, 38-39 and >39 years). RESULTS: A total of 1006 cycles from 914 women treated with Fertistartkit were included. At the time of first ovarian stimulation in the study, women were 34.9 ± 5.0 years old, with a median body mass index of 22.7 kg/m². Couples had been infertile for more than 4 years, with all patterns of causes of infertility. Ovarian stimulation was started with a median dose of 300 IU (interquartile range [IQR]: 150-300 IU) of Fertistartkit for 10 days (IQR: 9-11 days), so a median total dose of 2700 IU (IQR: 1800-3300 IU). The mean number of oocytes retrieved per cycle was 9.5 ± 6.8, and the mean number of mature oocytes per cycle was 7.4 ± 5.5. The obtained ongoing pregnancy per started cycle was 26.0% (95% confidence interval [CI]: 24.1-27.9) and the obtained ongoing pregnancy per puncture was 27.0% (95% CI: 25.0-29.0). CONCLUSIONS: This is the first cohort to describe Fertistartkit treatment management in real-life conditions. The real-world data show that Fertistartkit is an effective option for ovarian stimulation.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Languille S, Massin N, Santulli P, et al. Real-world effectiveness of Fertistartkit® treatment in women undergoing ART in French clinical practice: a retrospective multicentre study. Reprod Biomed Online. 2020. PMID: 32201114. doi:10.1016/j.rbmo.2020.01.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。